Generally, skin properties are highly specific for each individual depending on various factors such as genetic predisposition, age, gender, body region, health and lifestyle. In this study, we measured various skin parameters on forehead, temple and cheek of 442 Caucasian women between 23 and 63 years, and evaluated differences between these facial regions and also the relationship between skin parameters and age of the volunteers. We measured transepidermal water loss (TEWL), stratum corneum hydration, skin gloss, melanin level, individual typology angle (ITA), erythema, sebum level and elasticity (R7). We observed significant negative relationship between age and TEWL, elasticity and skin lightness represented by ITA. Sebum, melanin and erythema levels increased up to the age of 50, when menopause usually takes place, and then decreased again. Evaluating the skin parameters on the forehead, temple and cheek area, we observed the biggest differences between the cheek and the forehead. The cheek possessed the worst skin parameters, such as the highest TEWL and erythema values and the lowest hydration.

• MeSH
• běloši MeSH
• dospělí MeSH
• epidermis metabolismus   MeSH
• erytém epidemiologie   MeSH
• fyziologie kůže * MeSH
• lidé středního věku MeSH
• lidé MeSH
• obličej * MeSH
• perspiratio insensibilis MeSH
• pružnost MeSH
• sebum metabolismus   MeSH
• věkové faktory MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH

The Nijmegen Biomedical Study is a population-based cross-sectional study conducted in the eastern part of the Netherlands. As part of the overall study, we provide reference values of estimated glomerular filtration rate (GFR) for this Caucasian population without expressed risk. Age-stratified, randomly selected inhabitants received a postal questionnaire on lifestyle and medical history. In a large subset of the responders, serum creatinine was measured. The GFR was then measured using the abbreviated Modification of Diet in Renal Disease (MDRD) formula. To limit possible bias, serum creatinine was calibrated against measurements performed in the original MDRD laboratory. The study cohort included 2823 male and 3274 female Caucasian persons aged 18-90 years. A reference population of apparently healthy subjects was selected by excluding persons with known hypertension, diabetes, cardiovascular- or renal diseases. This healthy study cohort included 1660 male subjects and 2072 female subjects, of which 869 of both genders were 65 years or older. The median GFR was 85 ml/min/1.73 m(2) in 30-to 34-year-old men and 83 ml/min/1.73 m(2) in similar aged women. In these healthy persons, GFR declined approximately 0.4 ml/min/year. Our study provides age- and gender-specific reference values of GFR in a population of Caucasian persons without identifiable risk.

• MeSH
• běloši MeSH
• dospělí MeSH
• hodnoty glomerulární filtrace MeSH
• kalibrace MeSH
• kohortové studie MeSH
• lidé středního věku MeSH
• lidé MeSH
• průzkumy a dotazníky MeSH
• referenční hodnoty MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• sexuální faktory MeSH
• věkové faktory MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Geografické názvy
• Nizozemsko MeSH

OBJECTIVE: More parameters have been used for more detailed description of mechanical properties of human hair as a fibre than in analogous studies. All measured samples were taken from five different locations on the heads of 60 women of varied age. METHODS: For each hair, the diameter was determined optically and then the test in the Deform Type 2 testing machine was carried out. Deformation curves were obtained by testing 10 mm long samples up to the rupture point at constant temperature, humidity and constant crossbar speed of 2 mm/min. The curves were processed with software for the calculation of mechanical parameters of the hairs. This specialized software has been designed by us for that purpose. Resulting values were arranged into tables and figures. RESULTS: As far as hair cross-section is concerned, it has been found that for the European population it appears to be rather higher - 86 μm - than indicated in formerly published texts. The 56 μm mentioned in the work of other authors has been observed only utterly exceptionally, in 0.3 % of the population. All quantities studied (except extensibility) display moderate to strong positive skewness in comparison to Gauss distribution. The most marked skewness is seen in the resilience. At the same time, this quantity displays the highest value of non-Gaussian distribution. The elasticity module of 2.3±0.6 GPa is three times lower than the one reported by other authors, yet according to the fact published in our work - which shows unambiguously that the thinner the hair, the higher elasticity module it displays - the value of 7.2 GPa for the 56 µm thick hairs is comparable and it confirms the hypothesis that the cortex, which is responsible for the mechanical strength of the hair, is contained in a higher ratio in thinner hairs. This similarly applies to the ultimate strength; the linearity limit is hard to compare with literature, as it almost does not appear there. CONCLUSION: By measuring 886 samples from the heads of 60 adult women of European type, it was possible to ascertain the current norm for a larger number of mechanical parameters of the hairs. Further merit of this work is the fact that the hairs were taken systematically from five well-defined places of the studied heads in equal count, which is an aspect formerly published works do not respect and they do not present the location of sampling.

• MeSH
• běloši MeSH
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mechanický stres * MeSH
• mladiství MeSH
• mladý dospělý MeSH
• pevnost v tahu fyziologie   MeSH
• senioři MeSH
• vlasy, chlupy fyziologie   MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladiství MeSH
• mladý dospělý MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH

BACKGROUND: The c.1-67C variant polymorphism in a GATA motif of the FY promoter is known to result in erythroid-specific FY silencing, that is, in Fy(a-) and Fy(b-) phenotypes. A Caucasian donor presented with the very rare Fy(a-b-) phenotype and was further investigated. STUDY DESIGN AND METHODS: Genomic DNA was analyzed by sequencing to identify the cause of the Fy(a-b-) phenotype. Samples were collected from some of his relatives to establish a correlation between the serology and genotyping results. Red blood cells were analyzed by gel column agglutination and flow cytometry. Genomic DNA was analyzed on genotyping microarrays, by DNA sequencing and by allele-specific PCR. RESULTS: In the donor, a single-nucleotide polymorphism T>C within the GATA motif was found at Position c.1-69 of the FY promoter and shown to occur in the FY*A allele. His genotype was found to be FY*A(-69C), FY*BW.01. In six FY*A/FY*B heterozygous members of the family, a perfect correlation was found between the presence vs. absence of the FY*A(-69C) variant allele and a Fy(a-) vs. Fy(a+) phenotype. CONCLUSION: The location of the c.1-69C polymorphism in a GATA motif whose disruption is known to result in a Fy null phenotype, together with the perfect correlation between the presence of the FY*A(-69C) allele and the Fy(a-) phenotype support a cause-effect relationship between the two.

• MeSH
• alely MeSH
• běloši MeSH
• fenotyp MeSH
• genotyp MeSH
• jednonukleotidový polymorfismus genetika   MeSH
• krevní skupiny - systém Duffy genetika   MeSH
• lidé MeSH
• promotorové oblasti (genetika) genetika   MeSH
• rodokmen MeSH
• Check Tag
• lidé MeSH
• mužské pohlaví MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH

BACKGROUND: To date, no data have been reported on the pharmacokinetic and pharmacodynamic properties of landiolol, a fast-acting cardioselective β1-adrenergic antagonist, in non-Asian subjects. The aim of this study was to compare two landiolol formulations in healthy Caucasian subjects. MATERIALS AND METHODS: We conducted a single-center, prospective, double-blinded, randomized study in two cross-over periods with 12 healthy subjects (7 women and 5 men) each receiving three doses (0.1, 0.2, and 0.3mg/kg BW) of Onoact® 50 Lyophilized powder (50mg) or Rapibloc® concentrate IV (20mg/2mL) to evaluate the pharmacokinetics (PK), pharmacodynamics (PD), safety, and tolerability of the two landiolol formulations. RESULTS: For both formulations, maximum blood concentrations of landiolol were rapidly reached (median tmax 2.3±0.65 and 2.8±1.13min for the high dose of each formulation). The compounds had a short half-life (t1/2=3.2±1.2min and 3.0±1.1min for the low dose of the concentrate formulation and the lyophilized powder, respectively). The results showed no statistically significant differences between both formulations of landiolol for any PK parameters, at study doses. Both formulations dose-dependently and significantly decreased the heart rate values from 62.2bpm at baseline to minimum values of 55-56, 52-53, and 50-52bpm after 0.1, 0.2, and 0.3mg/kg respectively. This bradycardic effect was achieved within 1 to 3min. The decrease in systolic blood pressure (baseline: 107mmHg, minimum values were around 99mmHg) was significant but not dose dependent, and occurred within 3 to 12min. Seven mild to moderate AEs occurred after administration of the concentrate formulation. No SAEs were reported in this study. CONCLUSION: In Caucasians, both landiolol formulations showed similar pharmacokinetic behaviours, displaying very short half-lives (3.0 to 3.6min). In addition, after administration of both formulations, the landiolol-induced heart rate reduction showed fast onset and dose dependence, whilst the decrease of systolic blood pressure occurred more slowly, was less pronounced, and dose independent. In summary, both landiolol formulations delivered comparable plasma concentration profiles and showed good local tolerability. Overall, the pharmacokinetic and pharmacodynamic reactions observed in Caucasians were comparable to those described in Japanese subjects.

• MeSH
• běloši MeSH
• beta blokátory škodlivé účinky   chemie   farmakokinetika   farmakologie   MeSH
• dospělí MeSH
• dvojitá slepá metoda MeSH
• klinické křížové studie MeSH
• krevní tlak účinky léků   MeSH
• lidé MeSH
• mladiství MeSH
• mladý dospělý MeSH
• močovina škodlivé účinky   analogy a deriváty   chemie   farmakokinetika   farmakologie   MeSH
• morfoliny škodlivé účinky   chemie   farmakokinetika   farmakologie   MeSH
• příprava léků MeSH
• srdeční frekvence účinky léků   MeSH
• zdraví dobrovolníci pro lékařské studie MeSH
• Check Tag
• dospělí MeSH
• lidé MeSH
• mladiství MeSH
• mladý dospělý MeSH
• mužské pohlaví MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• randomizované kontrolované studie MeSH

The aim of our study was to evaluate differences between males and females based on patterns of costal cartilage ossification and also with respect to ageing. We provided diagnosis of ossifications from two files of radiograms. The first group consisted of 1044 chest and abdominal radiograms of patients (537 men and 507 women), ranging in age from 10 to 95 years obtained by using conventional X-ray technique. The second group was a set of 55 radiograms of chest plate fragments of cadavers (29 men and 26 women) aged from 15 to 98, obtained by using soft X-ray imaging in the skiagraphic-skiascopic unit. Ossifications were identified in more than 80% of the cases. They appear in puberta and their occurrence increases with age. The peripheral ossification pattern, typically the male pattern, is characterized by subperichondral deposits which contour the upper and lower margin of cartilage. The female, central lingual ossification pattern, is characterized by the pyramidal (lingual) shape of ossifications with a peak towards the sternum. The existence of another typical female central globular model of ossification was not confirmed in the file of cadavers. Central globular foci were found in both sexes (62% of women and 34% of men) from the 3rd decade. In the sample of Caucasian men and women (Czech population) we detected a frequent occurrence of costal cartilage ossification. Peripheral and central lingual patterns are highly predictive for sex determination. Globular loci of ossifications can be used for age estimation.

• MeSH
• běloši MeSH
• chrupavka radiografie   MeSH
• dítě MeSH
• dospělí MeSH
• heterotopická osifikace MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladiství MeSH
• mladý dospělý MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• soudní antropologie MeSH
• stárnutí MeSH
• určení kostního věku metody   MeSH
• určení pohlaví podle kostry metody   MeSH
• Check Tag
• dítě MeSH
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladiství MeSH
• mladý dospělý MeSH
• mužské pohlaví MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Geografické názvy
• Česká republika MeSH

Aim: Chemerin is a novel adipokine that has been suggested to play an important role in the pathogenesis of themetabolic syndrome. The aim of our study was to evaluate serum chemerin as a marker of the metabolic syndromeand to assess its predictive accuracy in a Caucasian population. Methods: The study was designed as a cross-sectional study. Anthropometric measurements and serum analyseswere done for Body Mass Index, waist circumference, chemerin, insulin, triacylglycerides, total cholesterol, HDLcholesterol,LDL-cholesterol, uric acid, and glucose in 55 non-obese healthy subjects and 181 subjects at risk for themetabolic syndrome. ROC curves were determined and the Chi-squared test was used to analyse the data. Results: Compared with healthy controls, subjects with suspected metabolic syndrome had signifi cantly higherchemerin serum levels (medians: 266.0 vs.192.5 µg/l; P < 0.01). After further chemerin adjustment, the diff erencebetween the subgroups persisted. Chemerin serum levels correlated with age (r = 0.23), serum glucose (r = 0.23),HDL-cholesterol (r = –0.19), triacylglycerides (r = 0.22), systolic and diastolic blood pressure (r = 0.40; r = 0.24) andthe number of metabolic syndrome risk factors (r = 0.47). At a serum chemerin cut-off level of 240 µg/l, the presenceof the metabolic syndrome was diagnosed with 75 % sensitivity and 67 % specifi city.Conclusion: In conclusion, serum chemerin levels are associated with the characteristics of the metabolic syndromeand could be an independent marker of this disorder in a Caucasian population.

• MeSH
• adipokiny izolace a purifikace   MeSH
• antropometrie metody   MeSH
• běloši etnologie   genetika   MeSH
• biologické markery krev   MeSH
• chemokiny izolace a purifikace   MeSH
• cholesterol izolace a purifikace   klasifikace   krev   MeSH
• ELISA metody   využití   MeSH
• glukosa izolace a purifikace   MeSH
• index tělesné hmotnosti MeSH
• inzulin izolace a purifikace   krev   MeSH
• kyselina močová izolace a purifikace   krev   MeSH
• lidé MeSH
• metabolický syndrom diagnóza   epidemiologie   genetika   MeSH
• průřezové studie MeSH
• statistika jako téma MeSH
• triglyceridy izolace a purifikace   krev   MeSH
• Check Tag
• lidé MeSH

Heritability studies have estimated the genetically attributable part of body mass index variance to be in the range of 30-70 %. Rs7566650 (G>C) single-nucleotide polymorphism (SNP) near the promoter of the INSIG2 gene has been identified as associated with body mass index. The gene product of INSIG2 is involved in regulation of fatty acid and cholesterol synthesis. In order to replicate this association we have analysed 2,559 unrelated individuals of Slavonic Caucasian origin from the populationbased Czech MONICA 3-year cohort. Body mass index, waist-hip ratio and plasma lipids (total-cholesterol, HDL-cholesterol, triglycerides) were measured at two independent examinations within three years. We could not detect any association between the SNP rs7566605 and body mass index, waist-hip ratio or lipid parameters, both with or without adjusting for age and gender. Neither the body mass index change nor lipid changes were significantly affected by the INSIG2 gene variant. Our results indicated that this INSIG2 polymorphism has no significant effect on body mass index and plasma lipids in the Czech Slavonic population.

• MeSH
• běloši genetika   MeSH
• dospělí MeSH
• financování organizované MeSH
• genetická predispozice k nemoci genetika   MeSH
• genotyp MeSH
• index tělesné hmotnosti MeSH
• intracelulární signální peptidy a proteiny genetika   MeSH
• lidé středního věku MeSH
• lidé MeSH
• lipidy krev   MeSH
• membránové proteiny genetika   MeSH
• obezita genetika   krev   MeSH
• polymorfismus genetický genetika   MeSH
• promotorové oblasti (genetika) genetika   MeSH
• senioři MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Geografické názvy
• Česká republika MeSH

BACKGROUND: Variable response after clopidogrel is well documented and may affect major adverse clinical events after stroke. Impact of CYP2C19 genetic polymorphisms is an established marker linked to variable response after clopidogrel. However, the association of certain genetic polymorphisms with prediction of major adverse clinical events following stroke still remains controversial, especially in Caucasians. STUDY QUESTION: The primary aim was to evaluate the impact of CYP2C19 allele *2 in heterozygote form on major adverse clinical events in Caucasian poststroke survivors treated with clopidogrel. The secondary aim was to analyze the potential link between CYP2C19 genetic polymorphism and variable response after clopidogrel. STUDY DESIGN: One hundred thirty patients of Caucasian origin following documented ischemic stroke were included. Platelet reactivity was assessed by light transmittance aggregometry (LTA) and matched with various CYP2C19 loss-of-function genetic polymorphisms and major adverse clinical events (composite of vascular deaths, stroke/transient ischemic attack, and myocardial infarction). RESULTS: Over the mean follow-up of 14.9 months, 19 patients experienced major adverse clinical events. The risk of major adverse clinical events was nearly 3-fold in loss-of-function allele carriers (hazard ratio = 2.904; 95% confidence interval, 1.083-7.786; P = 0.013), whereas the risk of ischemic stroke or transient ischemic attack alone was also higher (hazard ratio = 3.170; 95% confidence interval, 1.281-7.849; P = 0.034). Platelet activity was strongly associated with allele *2 status (rs = 0.21, P = 0.016) but not with other genetic polymorphisms. Carriers of allele*2 exhibited lower platelet response to adenosine diphosphate-mean LTA (30.1% vs. 42.0%; P = 0.017). There were no significant differences in LTA results with other agonists. Strong association of increase in adenosine diphosphate-induced aggregation with diabetes mellitus (rs = 0.20, P = 0.023), increasing age (rs = 0.23, P = 0.008), and conversely diminishing over increased weight (rs = 0.23, P = 0.009) was also detected. The carriers of other gene allele variants lack uniformed impact on variable response after clopidogrel. CONCLUSIONS: Even heterozygous CYP2C19*2 allele carriers among Caucasian patients after ischemic stroke had a higher risk of major adverse clinical events. The LTA, however, did not predict major adverse clinical events. The exact clinical utility of these findings is still uncertain and requires large outcome-driven randomized trial in Caucasians for proof of concept.

• MeSH
• agregace trombocytů účinky léků   MeSH
• běloši genetika   statistika a číselné údaje   MeSH
• biologické markery analýza   MeSH
• cévní mozková příhoda komplikace   farmakoterapie   genetika   MeSH
• cytochrom P450 CYP2C19 genetika   MeSH
• genotyp MeSH
• heterozygot MeSH
• hodnocení rizik MeSH
• infarkt myokardu epidemiologie   etiologie   genetika   prevence a kontrola   MeSH
• inhibitory agregace trombocytů farmakologie   terapeutické užití   MeSH
• lidé středního věku MeSH
• lidé MeSH
• mutace ztráty funkce MeSH
• polymorfismus genetický MeSH
• přežívající statistika a číselné údaje   MeSH
• retrospektivní studie MeSH
• senioři MeSH
• tiklopidin analogy a deriváty   farmakologie   terapeutické užití   MeSH
• tranzitorní ischemická ataka epidemiologie   etiologie   genetika   prevence a kontrola   MeSH
• věkové faktory MeSH
• výsledek terapie MeSH
• Check Tag
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH

INTRODUCTION: Automated bone age assessment has recently become increasingly popular. The aim of this study was to assess the agreement between automated and manual evaluation of bone age using the method according to Tanner-Whitehouse (TW3) and Greulich-Pyle (GP). METHODS: We evaluated 1285 bone age scans from 1202 children (657 scans from 612 boys) by using both manual and automated (TW3 as well as GP) bone age assessment. BoneXpert software versions 2.4.5.1. (BX2) and 3.2.1. (BX3) (Visiana, Holte, Denmark) were compared with manual evaluation using root mean squared error (RMSE) analysis. RESULTS: RMSE for BX2 was 0.57 and 0.55 years in boys and 0.72 and 0.59 years in girls, respectively for TW3 and GP. For BX3, RMSE was 0.51 and 0.68 years in boys and 0.49 and 0.52 years in girls, respectively for TW3 and GP. Sex- and age-specific analysis for BX2 identified the largest differences between manual and automated TW3 evaluation in girls between 6-7, 12-13, 13-14 and 14-15 years, with RMSE 0.88, 0.81, 0.92 and 0.84 years, respectively. The BX3 version showed better agreement with manual TW3 evaluation (RMSE 0.64, 0.45, 0.46 and 0.57). CONCLUSION: The latest version of the BoneXpert software provides improved and clinically sufficient agreement with manual bone age evaluation in children of both sexes compared to the previous version and may be used for routine bone age evaluation in non-selected cases in pediatric endocrinology care.

• MeSH
• běloši MeSH
• dítě MeSH
• lidé MeSH
• mladiství MeSH
• software * MeSH
• určení kostního věku * metody   MeSH
• Check Tag
• dítě MeSH
• lidé MeSH
• mladiství MeSH
• mužské pohlaví MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• validační studie MeSH